Cytek Biosciences Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Cytek Biosciences stock has a consensus rating of "Buy" and an average price target of $5.69. The average 1-year stock price forecast is 50.93% higher than the current stock price, while the lowest is $4.75 (+25.99%) and the highest is $7.50 (+98.94%).

Price Target: $5.69 (+50.93%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.75	$5.69	$5.25	$7.50
Change	+25.99%	+50.93%	+39.26%	+98.94%

* Price targets were last updated on May 13, 2026.

Analyst Ratings

The average analyst rating for Cytek Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	3	3	3	3	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mason Carrico Stephens	Stephens	Buy Reiterates $4.75	Buy	Reiterates	$4.75	+25.99%	May 13, 2026
Kallum Titchmarsh Morgan Stanley	Morgan Stanley	Hold Reiterates $5.5	Hold	Reiterates	$5.5	+45.89%	May 12, 2026
David Westenberg Piper Sandler	Piper Sandler	Buy Maintains $7.5	Buy	Maintains	$7.5	+98.94%	May 8, 2026
Brendan Smith TD Cowen	TD Cowen	Hold Maintains $5	Hold	Maintains	$5	+32.63%	May 8, 2026

Financial Forecast

Revenue This Year

208.83M

from 201.49M

3.64%

from 201.49M

Revenue Next Year

222.67M

from 208.83M

6.63%

from 208.83M

EPS This Year

-0.04

from -0.31

EPS Next Year

0.19

from -0.04

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	127.95M	164.04M	193.02M	200.45M	201.49M	208.83M
Revenue Growth	37.82%	28.20%	17.67%	3.85%	0.52%	3.64%
Gross Profit	79.14M	100.97M	109.43M	111.11M	104.46M	108.91M
Gross Margin	61.86%	61.56%	56.69%	55.43%	51.84%	52.15%
Operating Income	9.16M	-1.80M	-27.85M	-20.52M	-40.38M	-42.05M
Net Income	3.05M	2.58M	-12.15M	-6.02M	-66.54M	-40.94M
EPS	-	-	-	-	-0.31	-0.04
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	209.7M
Avg	208.8M
Low	208.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	4.1%
Avg	3.6%
Low	3.2%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.04
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-